• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏中自然杀伤细胞和自然杀伤T细胞发挥的抗肿瘤免疫作用。

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver.

作者信息

Nakashima Hiroyuki, Kinoshita Manabu

机构信息

Department of Immunology and Microbiology, National Defense Medical College, Saitama 359-8513, Japan.

出版信息

J Clin Med. 2023 Jan 21;12(3):866. doi: 10.3390/jcm12030866.

DOI:10.3390/jcm12030866
PMID:36769513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917438/
Abstract

The liver plays crucial roles in systemic immunity and greatly contributes to the systemic defense mechanism. Antitumor immunity in the liver is especially critical for the defense against systemic tumor cell dissemination. To achieve effective defense against metastatic tumor cells, liver immune cells with powerful cytotoxic activities construct a potent defense mechanism. In the liver, as compared with other organs, there is a significantly more intense percentage of innate immune lymphocytes, such as natural killer (NK) and NKT cells. These characteristic lymphocytes survey the portal blood transferred to the liver from the alimentary tract and eliminate malignant cells with their robust cytotoxic ability. Additionally, with their active cytokine-producing capacity, these innate lymphocytes initiate immunological sequences by adaptive immune cells. Therefore, they are crucial contributors to systemic antitumor immunity. These attractive immune cells help conduct a fundamental investigation of tumor immunity and act as a target of clinical measures for cancer therapies. This review discusses the mechanisms of these innate lymphocytes regarding recognition and cytotoxicity against tumor cells and the possibility of clinical applications for therapeutic measures.

摘要

肝脏在全身免疫中发挥着关键作用,并对全身防御机制有很大贡献。肝脏中的抗肿瘤免疫对于抵御全身肿瘤细胞播散尤为关键。为了实现对转移性肿瘤细胞的有效防御,具有强大细胞毒性活性的肝脏免疫细胞构建了一种有效的防御机制。与其他器官相比,肝脏中天然免疫淋巴细胞(如自然杀伤细胞和自然杀伤T细胞)的比例显著更高。这些具有特征性的淋巴细胞监测从消化道转移至肝脏的门静脉血,并以其强大的细胞毒性能力清除恶性细胞。此外,这些天然淋巴细胞凭借其活跃的细胞因子产生能力,启动适应性免疫细胞的免疫反应序列。因此,它们是全身抗肿瘤免疫的关键贡献者。这些引人注目的免疫细胞有助于开展肿瘤免疫的基础研究,并成为癌症治疗临床措施的靶点。本综述讨论了这些天然淋巴细胞识别肿瘤细胞及对其产生细胞毒性的机制,以及治疗措施临床应用的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30df/9917438/489d25a6d48a/jcm-12-00866-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30df/9917438/ce45322ee07c/jcm-12-00866-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30df/9917438/489d25a6d48a/jcm-12-00866-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30df/9917438/ce45322ee07c/jcm-12-00866-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30df/9917438/489d25a6d48a/jcm-12-00866-g002.jpg

相似文献

1
Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver.肝脏中自然杀伤细胞和自然杀伤T细胞发挥的抗肿瘤免疫作用。
J Clin Med. 2023 Jan 21;12(3):866. doi: 10.3390/jcm12030866.
2
Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.肝脏库普弗细胞、自然杀伤细胞、自然杀伤T细胞和CD8 CD122 T细胞产生的抗肿瘤免疫。
Clin Dev Immunol. 2011;2011:868345. doi: 10.1155/2011/868345. Epub 2011 Nov 29.
3
Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18.自然杀伤细胞而非自然杀伤T细胞在促进IL-18诱导的先天性抗肿瘤反应中发挥必要作用。
Int J Cancer. 2003 Feb 10;103(4):508-13. doi: 10.1002/ijc.10844.
4
Lipopolysaccharide preconditioning reduces liver metastasis of Colon26 cells by enhancing antitumor activity of natural killer cells and natural killer T cells in murine liver.脂多糖预处理通过增强自然杀伤细胞和自然杀伤 T 细胞在小鼠肝脏中的抗肿瘤活性来减少 Colon26 细胞的肝转移。
J Gastroenterol Hepatol. 2021 Jul;36(7):1889-1898. doi: 10.1111/jgh.15375. Epub 2020 Dec 31.
5
Anti-cancer activity of Angelica gigas by increasing immune response and stimulating natural killer and natural killer T cells.当归通过增强免疫应答和刺激自然杀伤细胞和自然杀伤 T 细胞来发挥抗癌作用。
BMC Complement Altern Med. 2018 Jul 18;18(1):218. doi: 10.1186/s12906-018-2277-7.
6
Natural killer T (NKT) cells and their role in antitumor immunity.自然杀伤T(NKT)细胞及其在抗肿瘤免疫中的作用。
Crit Rev Oncol Hematol. 2002 Mar;41(3):287-98. doi: 10.1016/s1040-8428(01)00198-6.
7
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.自然杀伤细胞和具有自然杀伤样活性的细胞在癌症免疫治疗中的临床观点。
Med Oncol. 2022 Jun 18;39(9):131. doi: 10.1007/s12032-022-01735-7.
8
Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.固有效应细胞在控制癌症进展中的正负作用。
Front Immunol. 2018 Sep 21;9:1990. doi: 10.3389/fimmu.2018.01990. eCollection 2018.
9
[Lectin populations of NK cells against tumors coupled to viral infections (review of literature).].[与病毒感染相关的NK细胞针对肿瘤的凝集素群体(文献综述)。]
Klin Lab Diagn. 2019;64(5):314-320. doi: 10.18821/0869-2084-2019-64-5-314-320.
10
Cross Talk Between Natural Killer T and Dendritic Cells and Its Impact on T Cell Responses in Infections.自然杀伤 T 细胞与树突状细胞之间的串扰及其对感染中 T 细胞反应的影响。
Front Immunol. 2022 Feb 3;13:837767. doi: 10.3389/fimmu.2022.837767. eCollection 2022.

引用本文的文献

1
Non-parenchymal cells: key targets for modulating chronic liver diseases.非实质细胞:调节慢性肝病的关键靶点。
Front Immunol. 2025 Jun 11;16:1576739. doi: 10.3389/fimmu.2025.1576739. eCollection 2025.
2
Leveraging liquid biopsy to uncover resistance mechanisms and guide personalized immunotherapy.利用液体活检揭示耐药机制并指导个性化免疫治疗。
Transl Oncol. 2025 Jun 24;59:102445. doi: 10.1016/j.tranon.2025.102445.
3
CTLs heterogeneity and plasticity: implications for cancer immunotherapy.CTLs 异质性和可塑性:对癌症免疫治疗的影响。

本文引用的文献

1
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead.NKT细胞免疫疗法的现状与未来挑战
Cancers (Basel). 2021 Oct 15;13(20):5174. doi: 10.3390/cancers13205174.
2
Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.B 急性淋巴细胞白血病中的嵌合抗原受体 T 细胞:现状与未来方向
Front Oncol. 2020 Aug 26;10:1594. doi: 10.3389/fonc.2020.01594. eCollection 2020.
3
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells.细胞毒性淋巴细胞中的颗粒酶 A 裂解 GSDMB 以在靶细胞中引发细胞焦亡。
Mol Cancer. 2024 Mar 21;23(1):58. doi: 10.1186/s12943-024-01972-6.
4
An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.一种用于预测肝细胞癌免疫治疗疗效和预后的免疫相关生物标志物指数。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10319-10333. doi: 10.1007/s00432-023-04899-5. Epub 2023 Jun 5.
Science. 2020 May 29;368(6494). doi: 10.1126/science.aaz7548. Epub 2020 Apr 16.
4
Gasdermin E suppresses tumour growth by activating anti-tumour immunity.Gasdermin E 通过激活抗肿瘤免疫来抑制肿瘤生长。
Nature. 2020 Mar;579(7799):415-420. doi: 10.1038/s41586-020-2071-9. Epub 2020 Mar 11.
5
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced Persistence and Antitumor Activity against Neuroblastoma.同时表达 GD2 特异性嵌合抗原受体和 IL15 的 NKT 细胞对神经母细胞瘤表现出增强的持久性和抗肿瘤活性。
Clin Cancer Res. 2019 Dec 1;25(23):7126-7138. doi: 10.1158/1078-0432.CCR-19-0421. Epub 2019 Sep 4.
6
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.抗 NKG2A mAb 是一种检查点抑制剂,通过释放 T 细胞和 NK 细胞来促进抗肿瘤免疫。
Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29.
7
Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.双重靶向 CD19 和 CD1d 增强 CAR19-iNKT 细胞的抗淋巴瘤活性。
Cancer Cell. 2018 Oct 8;34(4):596-610.e11. doi: 10.1016/j.ccell.2018.08.017.
8
Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells.CD1d表达的表观遗传诱导使肺癌细胞对不变自然杀伤T细胞的杀伤作用致敏。
Oncoimmunology. 2018 Feb 12;7(6):e1428156. doi: 10.1080/2162402X.2018.1428156. eCollection 2018.
9
CD4 T Cell and NK Cell Interplay Key to Regression of MHC Class I Tumors upon TLR7/8 Agonist Therapy.CD4 T 细胞和 NK 细胞相互作用是 TLR7/8 激动剂治疗后 MHC I 类肿瘤消退的关键。
Cancer Immunol Res. 2017 Aug;5(8):642-653. doi: 10.1158/2326-6066.CIR-16-0334. Epub 2017 Jun 21.
10
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.CD62L+自然杀伤T细胞在体内具有持久的存续能力和抗肿瘤活性。
J Clin Invest. 2016 Jun 1;126(6):2341-55. doi: 10.1172/JCI83476. Epub 2016 May 16.